🔗 Share this article

An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has taken down violative content and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.

Within moments of joining one community, a seller shared contact information, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Inside these groups, messages display black plastic packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already encountered individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially serious medical dangers”.